ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,983.99
      -0.29%
      US Tech 100
      20,480.38
      -0.36%
      Dow Jones
      43,910.98
      -0.86%
      Brent Oil
      71.835
      0.30%
      Bitcoin
      87,240.22
      -0.78%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Syros Pharmaceuticals Inc (SYRS)

      7. Syros Pharmaceuticals Inc (SYRS) Financials

      Syros Pharmaceuticals Inc

      Syros Pharmaceuticals Inc (SYRS)

      NASDAQ
      2.73
      -0.50
      (-15.48%)
      Closed November 13 4:00PM
      Delayed by 15 minutes
      0.367
      -2.36
      (-86.56%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Syros Pharmaceuticals Inc Financial Summary

      The current SYRS market cap is 9.85M. The company's latest EPS is USD -6.1334 and P/E is -0.45.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 3.76M386k000
      Operating Income -34.26M-27.51M-30.92M-27.42M-26.18M
      Net Income -40.14M-64.38M-3.71M-23.33M-6.4M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.98M15.09M23.49M14.88M9.94M
      Operating Income -77.74M-82.3M-99.42M-135.87M-128.99M
      Net Income -75.44M-84.04M-86.56M-94.65M-164.57M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 147.8M168.17M134.73M106.72M85M
      Total Liabilities 111.49M151.51M119.67M113.07M96.12M
      Total Equity 36.3M16.66M15.06M-6.35M-11.12M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 149.98M213.25M182.94M244.49M168.17M
      Total Liabilities 70.79M122.7M97.72M116.75M151.51M
      Total Equity 79.18M90.55M85.22M127.74M16.66M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -91.15M-109.71M-31.1M-60.77M-81.45M
      Investing 35.82M37.34M-24.64M427k427k
      Financing 82k43.46M-265k-224k-224k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -60.25M-57.36M-99.54M-123.07M-109.71M
      Investing -11.73M46.66M-52.65M67.19M37.34M
      Financing 65.99M142.95M70.51M131.05M43.46M

      Stats and Ratios

      Market Cap 9.85M
      Price to Earnings Ratio -0.45
      Price to Sales Ratio 7.37
      Price to Cash Ratio 0.53
      Price to Book Ratio 4.4
      Dividend Yield -

      Share Statistics

      Shares Outstanding 26.83M
      Average Volume (1 week) 408.79k
      Average Volume (1 Month) 525.52k
      52 Week Change -86.51%
      52 Week High 8.17
      52 Week Low 0.1569
      Spread (Intraday) 0.15 (37.44%)

      Company Info

      Company Name Syros Pharmaceuticals Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.syros.com
      Industry pharmaceutical preparations (2834)